结核-话题@MedSci

#结核#

628篇内容 | 8125人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1254362, encodeId=aff61254362e9, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=NEJM：与弥散性结核相关的HLH-病例报道, objectType=article, longId=193232, objectId=a5ef19323214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5ef19323214, replyNumber=0, likeNumber=43, createdTime=2020-05-01, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5ef19323214, moduleTitle=NEJM：与弥散性结核相关的HLH-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5ef19323214)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254361, encodeId=fbca125436163, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Lancet:全球艾滋病、结核病以及疟疾医疗支出变化研究, objectType=article, longId=192957, objectId=ac1719295ef2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac1719295ef2, replyNumber=0, likeNumber=88, createdTime=2020-04-27, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac1719295ef2, moduleTitle=Lancet:全球艾滋病、结核病以及疟疾医疗支出变化研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac1719295ef2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254360, encodeId=64de1254360c2, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学, objectType=article, longId=192368, objectId=f90c192368f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f90c192368f9, replyNumber=0, likeNumber=65, createdTime=2020-04-17, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f90c192368f9, moduleTitle=Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f90c192368f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254359, encodeId=660212543596b, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Eur Respir J：贝达喹啉 VS贝达喹啉-达拉米尼联合治疗耐多药结核病的效果, objectType=article, longId=192363, objectId=4e1e19236383, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1e19236383, replyNumber=0, likeNumber=74, createdTime=2020-04-17, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1e19236383, moduleTitle=Eur Respir J：贝达喹啉 VS贝达喹啉-达拉米尼联合治疗耐多药结核病的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e1e19236383)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254358, encodeId=36681254358fc, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=盆腔结核一例病案分析, objectType=article, longId=192337, objectId=9bbc19233e1b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bbc19233e1b, replyNumber=0, likeNumber=58, createdTime=2020-04-17, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bbc19233e1b, moduleTitle=盆腔结核一例病案分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bbc19233e1b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254357, encodeId=6a77125435e5e, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Clin Infect Dis：接受贝达喹啉或德拉马尼治疗的耐药结核病患者的临床结局, objectType=article, longId=192313, objectId=2b2a192313d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b2a192313d4, replyNumber=0, likeNumber=73, createdTime=2020-04-16, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b2a192313d4, moduleTitle=Clin Infect Dis：接受贝达喹啉或德拉马尼治疗的耐药结核病患者的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b2a192313d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254356, encodeId=2729125435602, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=【汇总】贝达喹啉联合德拉马尼治疗耐药性肺结核的疗效及安全性分析, objectType=article, longId=192282, objectId=70fc1922828e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70fc1922828e, replyNumber=0, likeNumber=0, createdTime=2020-04-16, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70fc1922828e, moduleTitle=【汇总】贝达喹啉联合德拉马尼治疗耐药性肺结核的疗效及安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70fc1922828e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254355, encodeId=c5ae125435574, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Lancet Respir Med：多重耐药性肺结核治疗中药物相关不良事件的发生, objectType=article, longId=192199, objectId=f2391921995d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2391921995d, replyNumber=0, likeNumber=83, createdTime=2020-04-15, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2391921995d, moduleTitle=Lancet Respir Med：多重耐药性肺结核治疗中药物相关不良事件的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2391921995d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254354, encodeId=1283125435469, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Clin Infect Dis：在南非接受耐多药/耐利福平肺结核治疗的孕妇的母婴结局, objectType=article, longId=192197, objectId=d75019219e9e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d75019219e9e, replyNumber=0, likeNumber=0, createdTime=2020-04-15, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d75019219e9e, moduleTitle=Clin Infect Dis：在南非接受耐多药/耐利福平肺结核治疗的孕妇的母婴结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d75019219e9e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254353, encodeId=49d9125435331, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Clinica Chimica Acta：血清人附睾蛋白4浓度与肺结核患者病情严重程度相关？, objectType=article, longId=192159, objectId=3f2e192159f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f2e192159f3, replyNumber=0, likeNumber=67, createdTime=2020-04-14, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f2e192159f3, moduleTitle=Clinica Chimica Acta：血清人附睾蛋白4浓度与肺结核患者病情严重程度相关？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f2e192159f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254352, encodeId=88581254352ae, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=含贝达奎宁的短期疗程方案治疗耐多药结核病的成本效益分析, objectType=article, longId=191963, objectId=c76e19196362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c76e19196362, replyNumber=0, likeNumber=62, createdTime=2020-04-12, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c76e19196362, moduleTitle=含贝达奎宁的短期疗程方案治疗耐多药结核病的成本效益分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c76e19196362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254351, encodeId=76d0125435193, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle= Eur Respir J：抗药性肺结核患者使用贝达奎林-达拉米尼联合治疗是否优于贝达奎林单药治疗的效果？, objectType=article, longId=191951, objectId=4482191951c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4482191951c9, replyNumber=0, likeNumber=77, createdTime=2020-04-11, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4482191951c9, moduleTitle= Eur Respir J：抗药性肺结核患者使用贝达奎林-达拉米尼联合治疗是否优于贝达奎林单药治疗的效果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4482191951c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254350, encodeId=6baf1254350b9, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Respir Investig：贝达奎林治疗耐多药结核病的效果和安全性, objectType=article, longId=191941, objectId=7162191941b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7162191941b9, replyNumber=0, likeNumber=63, createdTime=2020-04-11, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7162191941b9, moduleTitle=Respir Investig：贝达奎林治疗耐多药结核病的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7162191941b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254349, encodeId=7593125434901, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=贝达奎宁治疗耐多药和广泛耐药结核：安全有效, objectType=article, longId=191934, objectId=f08b19193483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f08b19193483, replyNumber=0, likeNumber=0, createdTime=2020-04-11, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f08b19193483, moduleTitle=贝达奎宁治疗耐多药和广泛耐药结核：安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f08b19193483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254348, encodeId=4ae31254348d1, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Clin Infect Dis：耐药肺结核患者接受含贝达奎林或德拉米尼的治疗方案的临床结果, objectType=article, longId=191921, objectId=bb121919210c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb121919210c, replyNumber=0, likeNumber=48, createdTime=2020-04-11, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb121919210c, moduleTitle=Clin Infect Dis：耐药肺结核患者接受含贝达奎林或德拉米尼的治疗方案的临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb121919210c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254347, encodeId=22a8125434e4e, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=J Infect：临床结核病分离株对贝达奎林的易感性和耐药性降低, objectType=article, longId=191920, objectId=1c43191920a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c43191920a4, replyNumber=0, likeNumber=60, createdTime=2020-04-11, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c43191920a4, moduleTitle=J Infect：临床结核病分离株对贝达奎林的易感性和耐药性降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c43191920a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254346, encodeId=c726125434655, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=BMC Infect Dis：在中国采用含贝达喹啉治疗方案对耐药性结核病负担的长期影响, objectType=article, longId=191919, objectId=42e3191919a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42e3191919a1, replyNumber=0, likeNumber=60, createdTime=2020-04-11, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42e3191919a1, moduleTitle=BMC Infect Dis：在中国采用含贝达喹啉治疗方案对耐药性结核病负担的长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42e3191919a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254345, encodeId=3a83125434538, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Clin Infect Dis：接受治疗后，耐多药/耐利福平结核病孕妇的母婴结局, objectType=article, longId=191909, objectId=36b9191909dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36b9191909dc, replyNumber=0, likeNumber=89, createdTime=2020-04-11, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36b9191909dc, moduleTitle=Clin Infect Dis：接受治疗后，耐多药/耐利福平结核病孕妇的母婴结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36b9191909dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254344, encodeId=f743125434433, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=Lancet Respir Med：耐多药结核病治疗过程中不良事件的发生, objectType=article, longId=191901, objectId=0b6c1919011b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b6c1919011b, replyNumber=0, likeNumber=107, createdTime=2020-04-11, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b6c1919011b, moduleTitle=Lancet Respir Med：耐多药结核病治疗过程中不良事件的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b6c1919011b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1254343, encodeId=9298125434347, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, objectTitle=贝达奎宁治疗耐多药结核病的美国经验 , objectType=article, longId=191820, objectId=b450191820c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b450191820c1, replyNumber=0, likeNumber=0, createdTime=2020-04-10, rootId=0, userName=huhuaidong387, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b450191820c1, moduleTitle=贝达奎宁治疗耐多药结核病的美国经验 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b450191820c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

结核

2020-05-29发表于威斯康星

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

NEJM：与弥散性结核相关的HLH-病例报道

2020-05-01

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Lancet:全球艾滋病、结核病以及疟疾医疗支出变化研究

2020-04-27

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Respir Investig：贝达喹啉在日本耐肺多药结核病患者中的安全性，有效性和药代动力学

2020-04-17

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Eur Respir J：贝达喹啉 VS贝达喹啉-达拉米尼联合治疗耐多药结核病的效果

2020-04-17

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

盆腔结核一例病案分析

2020-04-17

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Clin Infect Dis：接受贝达喹啉或德拉马尼治疗的耐药结核病患者的临床结局

2020-04-16

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

【汇总】贝达喹啉联合德拉马尼治疗耐药性肺结核的疗效及安全性分析

2020-04-16

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Lancet Respir Med：多重耐药性肺结核治疗中药物相关不良事件的发生

2020-04-15

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Clin Infect Dis：在南非接受耐多药/耐利福平肺结核治疗的孕妇的母婴结局

2020-04-15

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Clinica Chimica Acta：血清人附睾蛋白4浓度与肺结核患者病情严重程度相关？

2020-04-14

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

含贝达奎宁的短期疗程方案治疗耐多药结核病的成本效益分析

2020-04-12

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Eur Respir J：抗药性肺结核患者使用贝达奎林-达拉米尼联合治疗是否优于贝达奎林单药治疗的效果？

2020-04-11

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Respir Investig：贝达奎林治疗耐多药结核病的效果和安全性

2020-04-11

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

贝达奎宁治疗耐多药和广泛耐药结核：安全有效

2020-04-11

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Clin Infect Dis：耐药肺结核患者接受含贝达奎林或德拉米尼的治疗方案的临床结果

2020-04-11

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

J Infect：临床结核病分离株对贝达奎林的易感性和耐药性降低

2020-04-11

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

BMC Infect Dis：在中国采用含贝达喹啉治疗方案对耐药性结核病负担的长期影响

2020-04-11

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Clin Infect Dis：接受治疗后，耐多药/耐利福平结核病孕妇的母婴结局

2020-04-11

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

Lancet Respir Med：耐多药结核病治疗过程中不良事件的发生

2020-04-11

huhuaidong387 (审核中...)

前往app查看评论内容

#结核#

贝达奎宁治疗耐多药结核病的美国经验

2020-04-10

科室
- - 订阅+
  - 更多科室
工具
服务